Skip to content
lifestyle.brownplanet.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
InnoCare Pharma
InnoCare Announces First Patient Dosed in Phase III Trial of Orelabrutinib for SLE
April 28, 2026
InnoCare Releases 2026 Q1 Results: Strong Revenue Growth and Sustained Profitability
April 23, 2026
Preclinical Data of Novel B7-H3 ADC ICP-B794 Unveiled at 2026 AACR, Demonstrating Superior Anti-Tumor Activity and Safety
April 21, 2026
InnoCare Releases 2025 Results and Business Highlights, Achieving First Annual Profit
March 25, 2026
←
Previous Page
1
2
3